Background
Diabetes
TYPE 2 DIABETES, DIABETES
Edited by: Pranav Kumar Prabhakar, Lovely Professional University, IndiaReviewed by: Gopal L. Khatik, National Institute of Pharmaceutical Education and Research, India; Ewan Pearson, University of Dundee, United KingdomThis article was submitted to Clinical Diabetes, a section of the journal Frontiers in EndocrinologyUnderstanding which group of patients with type 2 diabetes will have the most glucose lowering response to certain medications (which target different aspects of glucose metabolism) is the first step in precision medicine.